Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.477
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0646
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0741
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.912
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.276
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.274
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.487
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HOM
|
284f:461m
|
|
|
NotProcessed |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0856
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0647
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
284f:461m
|
|
|
NotProcessed |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
6.61×10-08
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0856
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.639
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
20f:25m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
30f:10m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.139
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0772
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.835
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0197
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.481
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.283
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.219
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.184
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.276
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.605
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0715
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.994
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.412
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.339
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:133m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.358
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.541
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0105
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.112
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.962
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.633
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
4.56×10-06
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.236
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.105
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.179
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
2f:m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.126
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0128
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00108
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.213
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.606
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.762
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:133m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
1.11×10-05
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.257
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.609
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0839
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.407
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00114
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.486
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0121
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.497
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
4f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.743
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0248
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.176
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.102
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0246
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:133m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
2f:m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.168
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Dysmorphology / Body fat distribution
|
HOM
|
10f:7m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
142f:294m
|
|
|
NotProcessed |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0731
|
Successful |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Dlg4tm1Grnt
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.707
|
Successful |
Dlg4tm1e(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.520
|
Successful |